Merck & Co offloads contract biomanufacturing ops to Fujifilm

In an apparent move to shed a non-core business, Merck & Co has decided that it no longer wants to run its own in-house capability for the contract manufacture of biologics, although it will still have access to the operations that it has built up in this sector.